CIK 0001211583
- Non-accelerated filer
- Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 919-636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,550,718
- in 5 filings, $1.4M under 10b5-1 plans
Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 7 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | RALLIS CHRIS A Director | Grant or award · Stock Option | +20,000 | $8.70 | $174K | 200,000 |
| 2026-05-11 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +14,344 | $2.44 | $35K | 71,423 |
| 2026-05-11 | RALLIS CHRIS A Director | Sale 10b5-1 | −8,346 | $7.04 | $59K | 63,077 |
| 2026-05-11 | RALLIS CHRIS A Director | Exercise or conversion · Stock Option 10b5-1 | −14,344 | $2.44 | $35K | 186,189 |
| 2025-10-10 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +4,062 | $1.23 | $5K | 58,854 |
| 2025-10-10 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,775 | $9.24 | $16K | 57,079 |
| 2025-10-10 | RALLIS CHRIS A Director | Exercise or conversion · Common Shares 10b5-1 | −4,062 | $1.23 | $5K | 174,344 |
| 2025-07-07 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +2,127 | $2.35 | $5K | 55,911 |
| 2025-07-07 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,119 | $8.71 | $10K | 54,792 |
| 2025-07-07 | RALLIS CHRIS A Director | Exercise or conversion · Common Shares 10b5-1 | −2,127 | $2.35 | $5K | 178,406 |
| 2025-06-03 | RALLIS CHRIS A Director | Grant or award · Stock Option | +20,000 | $7.88 | $158K | 200,533 |
| 2025-04-11 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +2,173 | $2.30 | $5K | 55,193 |
| 2025-04-11 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,409 | $4.95 | $7K | 53,784 |
| 2025-04-11 | RALLIS CHRIS A Director | Exercise or conversion · Common Shares 10b5-1 | −2,173 | $2.30 | $5K | 180,533 |
| 2025-02-14 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +1,992 | $2.51 | $5K | 54,206 |
| 2025-02-14 | RALLIS CHRIS A Director | Sale 10b5-1 | −1,186 | $6.82 | $8K | 53,020 |
| 2025-02-14 | RALLIS CHRIS A Director | Exercise or conversion · Common Shares 10b5-1 | −1,992 | $2.51 | $5K | 182,706 |
| 2024-12-02 | RALLIS CHRIS A Director | Exercise or conversion 10b5-1 | +10,000 | $2.69 | $27K | 58,623 |
| 2024-12-02 | RALLIS CHRIS A Director | Sale 10b5-1 | −6,409 | $6.14 | $39K | 52,214 |
| 2024-12-02 | RALLIS CHRIS A Director | Exercise or conversion · Common Shares 10b5-1 | −10,000 | $2.69 | $27K | 184,698 |
Page 1 of 4 · 64 trades